TCL Archive “Sloppy” Searle Studies Described By FDA At Kennedy Hearing; Rauscher “Outraged” January 23, 1976
TCL Archive In Brief: More Money, Not Reorganization, Is Needed For Clinical Research, Paul Carbone Argues November 10, 1978
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive In Brief: FASEB Recommends $11.75 Billion NIH Budget; Natcher Wins House Appropriations Chairmanship December 11, 1992
